Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 Dec 23;4(12):e004983.
doi: 10.1136/bmjopen-2014-004983.

Awareness and control of hypertension in Bangladesh: follow-up of a hypertensive cohort

Affiliations
Clinical Trial

Awareness and control of hypertension in Bangladesh: follow-up of a hypertensive cohort

Dewan Shamsul Alam et al. BMJ Open. .

Abstract

Objectives: To assess the effect of awareness and advice to seek care on blood pressure (BP) control among patients with hypertension in Bangladesh.

Design: Longitudinal study.

Setting: The study was carried out in icddr,b surveillance sites at rural Matlab in Chandpur district and semi-urban Kamalapur in Dhaka, Bangladesh.

Participants: Randomly selected men and non-pregnant women aged 20 years or older without any acute illness or history of any vascular events such as stroke or acute myocardial infarction.

Main outcome measure: Hypertension was defined as systolic BP (SBP) ≥140 and/or diastolic BP (DBP) ≥90 mm Hg or as self-reported hypertension under medication. We advised patients to seek care from a qualified provider and to adopt a healthy lifestyle. We compared changes in BP from baseline to follow-up at around 6 months.

Results: Overall, 17.1% (n=287) of participants had hypertension at baseline with significantly higher prevalence in the semi-urban than in the rural population (23.6% vs 10.8%; p<0.001); half were unaware of their condition. At follow-up, 83% (n=204) reported a visit to any healthcare provider. In the semi-urban area, a higher proportion of patients visited medically qualified practitioners than in the rural area (76.7% vs 36.6%, p<0.000). SBP (-3.3±20.7 mm Hg; p<0.01) and DBP (-2.0±13.0 mm Hg; p<0.02) were lower at follow-up. Those who visited medically qualified practitioners had significant SBP (-3.9±22.4 mm Hg; p<0.03) and DBP (-2.7±14.1 mm Hg; p<0.02) reduction. BP reduction did not reach statistical significance among those visiting a pharmacist or their village doctors. Overall, half of the patients with hypertension achieved the BP control goal (BP<140/90 mm Hg).

Conclusions: Awareness and simple health messages increase provider visit, reduce blood pressure and improve BP control in hypertensive Bangladeshis. Longer-term follow-up is required to verify the sustainability.

Keywords: EPIDEMIOLOGY; PRIMARY CARE; PUBLIC HEALTH.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study enrolment and follow-up flow diagram. BP, blood pressure.
Figure 2
Figure 2
Distribution of awareness and control of blood pressure among patients with hypertension at baseline and at follow-up by area of residence in Bangladesh. HTN, hypertension.
Figure 3
Figure 3
Pattern of health care provider visits and medication use in urban Dhaka and rural Matlab, Bangladesh. (A) Distribution of provider visits by area and economic strata. (B) Pattern of medication use by area and provider type. *Professionals included MBBS/MD or higher educated health care providers. Drug sellers included pharmacists, village doctors or owners of small drug outlets with or without diplomas or certificates for medical practice. BB, β-blockers; CCB, calcium channel blockers; ARB, angiotensin receptor blockers.
Figure 4
Figure 4
Change in systolic and diastolic blood pressure between baseline and follow-up by provider type. *Professionals included MBBS/MD or higher educated health care providers. Drug sellers included pharmacists, village doctors or owners of small drug outlets with or without any diplomas or certificates for medical practice. DBP, diastolic blood pressure; SBP, systolic BP.

References

    1. Kearney PM, Whelton M, Reynolds K et al. . Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217–23. 10.1016/S0140-6736(05)17741-1 - DOI - PubMed
    1. Lawes CMM, Hoorn SV, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 2008;371:1513–18. 10.1016/S0140-6736(08)60655-8 - DOI - PubMed
    1. Qureshi AI, Suri MF, Kirmani JF et al. . Is prehypertension a risk factor for cardiovascular diseases? Stroke 2005;36:1859–63. 10.1161/01.STR.0000177495.45580.f1 - DOI - PubMed
    1. Hsia J, Margolis KL, Eaton CB et al. . Prehypertension and cardiovascular disease risk in the women's health initiative. Circulation 2007;115:855–60. 10.1161/CIRCULATIONAHA.106.656850 - DOI - PubMed
    1. Crews DC, Plantinga LC, Miller ERI et al. . Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States. Hypertension 2010;55:1102–9. 10.1161/HYPERTENSIONAHA.110.150722 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources